aDAPt-ANOCA: Dapagliflozin for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)

NCT07741890 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Angina With Non-Obstructive Coronary Artery Disease
Coronary Microvascular Dysfunction (CMD)

Interventions

DRUG: Dapagliflozin (10mg Tab)
DRUG: Placebo ( FE)

Sponsor

The Christ Hospital